Global Information
회사소개 | 문의 | 비교리스트

OTC 의약품, 의료기기, 진단약 : 세계 시장

OTC Drugs, Medical Devices and Diagnostics: Global Markets

리서치사 BCC Research
발행일 2020년 06월 상품 코드 941891
페이지 정보 영문 317 Pages
가격
US $ 5,500 ₩ 6,066,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,279,000 PDF (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 8,735,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,504 ₩ 10,482,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


OTC 의약품, 의료기기, 진단약 : 세계 시장 OTC Drugs, Medical Devices and Diagnostics: Global Markets
발행일 : 2020년 06월 페이지 정보 : 영문 317 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 OTC 의약품, 의료기기, 진단약 시장 규모는 2019-2024년간 6.9%의 연평균 복합 성장률(CAGR)로 성장하여 2019년 2,590억 달러에서 2024년에는 3,610억 달러까지 확대될 것으로 예측됩니다.

세계의 OTC(over the counter) 의약품/의료기기/진단약 시장 분석, 제품 요약 및 시장의 기본 구조(대상이 되는 주요 질환 및 장애 등), 현재의 시장 범위 및 충족되지 않은 욕구, 시장 규모와 성장률 동향 전망, 주요 시장 성장 촉진요인 및 억제요인, 현재의 연구개발 및 자본거래 동향과 전망, 규제 환경, 향후 시장 성장 가능성 및 방향성, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 요약 및 하이라이트

제3장 대상 질환 및 장애

  • OTC의 대상이 되는 일반 질병 및 장애 : 개요
    • 순환기 질환
    • 생활습관병
    • 호흡기 질환
    • 근골격 장애
    • 정신장애/기분장애
    • 위장장애
    • 비뇨기과 질환
    • 만성 상처
    • 만성 통증
    • 공황장애/불안장애
    • 이비인후과(ENT) 질환
    • 치과 질환
    • 섭식장애
  • 흡연과 관련된 질환
  • 만성질환 : OTC 시장 범위를 확장
  • 나이/성별과 질병 발병
    • 세계 인구 통계
    • 미국 인구 통계
    • 미국 : 성별, 연령, 평균 수명
    • 유럽의 인구 통계
    • 일본의 인구 통계
  • 현재의 과제와 향후의 방향성

제4장 OTC 의약품과 영양보충제

  • OTC 의약품 개요
  • OTC 의약품의 진화
  • 약물의 임상적 필요성
  • 약물 기반 질병 관리
    • 제네릭 의약품과 질병 관리
    • 제네릭 의약품과 브랜드 의약품
    • 제네릭에 대한 지속적인 거부감
  • OTC 의약품과 유형
    • OTC 진통제/해열제
    • OTC 항히스타민제/기침약/감기약
    • OTC 위장약
    • OTC 피부과 약물
    • OTC 구강 케어 제품
    • OTC 아이 케어 제품
    • OTC 금연 제품
  • 주요 출시 OTC 의약품
  • OTC 영양보충제와 그 종류
    • 섭식장애
    • 비타민/미네랄 결핍증 치료
    • 비타민/미네랄 보충제(VMS)
  • OTC 유통채널
    • 다국적 OTC 의약품 제조
    • 약국, 기타 체인점 브랜드
    • 일용소비재(FMCG)
  • OTC 의약품 구매의 실천
  • OTC 의약품 시장에 대한 규제의 영향
  • OTC 의약품/영양보충제 시장 상황
    • 선진국 시장
    • 개발도상국 시장
    • 저개발국 시장
  • 치료와 비용 부담
  • 충족되지 않은 욕구
  • 현재의 과제와 향후의 전개

제5장 OTC 의료기기/진단약

  • 의료기기, 진단, 질병 관리
  • OTC 의료기기 및 진단약 : 임상 현장/시장에서 필요
  • OTC 의료기기 및 진단약의 종류
    • 자가치료용 기기 및 웨어러블 기기
    • 진단 기기 및 키트
  • 주요 제품
    • 진단 및 모니터링 기기
    • 치료 기기와 기술
  • 원격 환자 모니터링 및 재택치료
  • 디지털 치료에 의한 질병 관리의 이점
  • 충족되지 않은 욕구
  • 현재의 과제
  • 향후 전망

제6장 치료 준수(Treatment Adheremce)를 위한 OTC 기기

  • 치료 불응
  • OTC 의약품 복약 준수 기기 시장 요구
  • 하드웨어 중심 OTC 복약 준수 기기
    • 스마트 약병
    • 자동 알약 디스펜서
    • 전자 트레이
    • 스마트 캡
    • 기타 준수 기기와 솔루션
  • 주요 제품
    • 스마트 알약 디스펜서, 알약 상자, Organizers, 스마트 알약 캡, 병 시스템
    • 기타 OTC 준수 기기
  • 현재의 과제
  • 향후의 전개

제7장 시장 규모와 성장 분석

  • 시장 규모와 성장률 분석
    • 시장 규모와 성장률 분석 : 지역별
    • 시장 규모와 성장률 분석 : 제품별
    • 시장 규모와 성장률 분석 : 질환 종류별
  • 시장 성장 촉진요인 및 억제요인
  • OTC 시장에 대한 규제의 영향
  • 유럽 OTC 시장에 대한 브렉시트(Brexit)의 영향
  • OTC 시장의 SWOT 분석

제8장 OTC 의약품, 의료기기, 진단약 시장의 경쟁 상황

  • 기업간 경쟁 상황 환경 : OTC 의약품, 의료기기, 진단 기술별 질환 치료 및 관리

제9장 OTC 의약품, 의료기기, 진단약 시장 전략

  • OTC 의약품 및 의료기기 시장에서의 기업 재편
  • OTC 의약품, 의료기기, 진단약 시장에서의 기업 인수 합병(M&A)
  • 최근의 M&A
  • 향후의 전략적 전망

제10장 규제 구조 : 의약품, 의료기기, 진단약

  • 규제의 배경
  • 의료기기 규제 제도 : 지역별
    • 미국
    • 유럽
    • 일본
  • 의약품 규제 제도 : 지역별
  • OTC 의약품 및 영양보충제 규칙과 규제

제11장 가격과 상환 : 의약품, 의료기기, 진단약

  • 가격과 의료비 상환 배경
  • 의료기기 가격 및 의료비 상환 : 지역별
  • 의약품 가격 및 의료비 상환 : 지역별

제12장 결론 : OTC 의약품, 의료기기, 진단약 시장 전망

  • 시장에 영향을 미치는 주요 동향
    • 기술 개발
    • 인구동태 및 경제 동향
    • 의료 산업의 구조 변화
    • 라이프스타일 의학
    • 환자 중심의 프로그램
    • Self-Care의 보급
    • 공중보건 시스템에 대한 부담
    • 시장 리더십 유지
  • 장기적 전망

제13장 기업 개요

  • 3M
  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • ACADIA PHARMACEUTICAL
  • ACORDA THERAPEUTICS
  • ACTAVIS PLC
  • ACTUALMEDS
  • ADHERIUM
  • AETHLON MEDICAL INC.
  • AGENUS
  • AKRON
  • ALACER CORP.
  • ALCON INC.
  • ALERE INC.
  • ALFRESA PHARMA CORP.
  • ALIPHCOM INC.
  • ALIVECOR
  • ALKALON A/S
  • ALKERMES
  • ALLERGAN
  • ALLIANCE HEALTHCARE
  • AMGEN INC.
  • AMIKO
  • AMNEAL PHARMACEUTICALS
  • ANAVEX LIFE SCIENCES
  • ANI PHARMACEUTICALS
  • ANIMAS (A SUBSIDIARY OF JOHNSON & JOHNSON)
  • APOTEX
  • ARCHOS
  • ARENA PHARMACEUTICALS
  • ARRAY BIOPHARMA
  • ASAHI KASAI CORP.
  • ASLAN PHARMACEUTICALS
  • ASPEN PHARMACARE
  • ASSERTIO THERAPEUTICS, INC.
  • ASTELLAS PHARMA INC.
  • ASTRAZANECA PLC
  • ATHERSYS
  • AUDENTES THERAPEUTICS
  • AXIOBIONICS
  • AXSOME THERAPEUTICS
  • BAUSCH & LOMB
  • BAUSCH HEALTH
  • BAXTER INTERNATIONAL INC.
  • BAYER AG
  • BEIGENE
  • BESPAK EUROPE
  • BIOMERIEUX
  • BIOSENSICS
  • BIOSERENITY
  • BIOTRICITY
  • BIOTRONIK
  • BIOVOTION
  • BIOXCEL THERAPEUTICS
  • BODYTEL
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRAINMARC
  • BRISTOL-MYERS SQUIBB
  • BTS BIOENGINEERING
  • CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
  • CARMA LABORATORIES, INC.
  • CELGENE
  • CHATTEM INC.
  • CHUGAI PHARMACEUTICALS CO. LTD.
  • CILAG AG
  • CIPLA
  • CLEVELAND MEDICAL DEVICES
  • COLGATE-PALMOLIVE CO.
  • CONNECTEDHEALTH PTE. LTD.
  • CONSORT MEDICAL
  • CORBUS PHARMACEUTICALS
  • CSPC PHARMACEUTICAL GROUP
  • DAIICHI SANKYO
  • DERMA SCIENCES
  • DEXCOM INC.
  • DR. REDDY'S LABORATORIES LTD.
  • EARLYSENSE
  • 자이
  • ELI LILLY AND CO.
  • EMPATICA
  • ENDO INTERNATIONAL
  • ENDOCEUTICS INC.
  • ENDOTRONIX
  • ENTRA HEALTH SYSTEMS
  • ERYTECH PHARMA
  • ESTEVE
  • EVERIST HEALTH
  • EYESCIENCE LABS
  • FERTIN PHARMA A/S
  • GABA SCHWEIZ
  • GALDERMA SA
  • GEMINI PHARMACEUTICALS INC.
  • GENOMMA LAB INTERNATIONAL
  • GENOMMA LAB USA
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • GLOOKO INC.
  • GLUCOVISTA INC.
  • HEALTH CARE ORIGINALS
  • HIKMA PHARMACEUTICALS
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • HOCOMA
  • IHEALTH LAB INC.
  • IMMUNOMEDICS
  • IMPACT SPORTS TECHNOLOGIES
  • IMPAK HEALTH
  • INFOBIONIC INC.
  • INSULET CORP.
  • INTELESENS
  • INTRA-CELLULAR THERAPIES
  • IOVANCE BIOTHERAPEUTICS
  • IPSEN SA
  • JAN MEDICAL INC.
  • JIANGSU HENGRUI MEDICINE
  • JOHNSON & JOHNSON
  • KOWA CO. LTD.
  • KYOWA HAKKO KIRIN
  • LAKE CONSUMER PRODUCTS INC.
  • LES LABORATOIRES SERVIER
  • LIVANOVA PLC
  • LUNDBECK
  • LUPIN
  • MALLINCKRODT PLC
  • MANX HEALTHCARE LTD.
  • MCM KLOSTERFRAU VERTRIEBS GMBH(KLOSTERFRAU HEALTHCARE GROUP)
  • MEDA AB
  • MEDMINDER
  • MEDTRONIC
  • MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
  • MELALEUCA INC.
  • MENARINI
  • MERCK
  • MERZ PHARMA
  • MIO GLOBAL
  • MITSUBISHI TANABE PHARMA
  • MOCHIDA PHARMACEUTICAL CO. LTD.
  • MYCARDIO LLC
  • MYLAN INC.
  • NEMAURA MEDICAL INC.
  • NEOFECT CO. LTD.
  • NEUROCRINE BIOSCIENCES
  • NEUROMETRIX INC.
  • NEUROVIGIL INC.
  • NEUTROGENA CORP.
  • NORTHEAST PHARMACEUTICAL GROUP CO. LTD.
  • NOVARTIS
  • NOVASOM INC.
  • NOVO NORDISK
  • NOW FOODS
  • NUCANA
  • OMADA HEALTH INC.
  • OMNICELL INC.
  • OMRON CORP
  • ONO PHARMACEUTICAL CO. LTD.
  • ORION PHARMA LTD.
  • ORPYX MEDICAL TECHNOLOGIES
  • OTSUKA PHARMACEUTICALS
  • PACIRA PHARMACEUTICALS INC.
  • PERRIGO PLC
  • PFIZER
  • PGT HEALTHCARE (DIVISION OF PROCTER & GAMBLE
  • PHARMAVITE LLC
  • PHILOSYS
  • PIERRE FABRE PHARMACEUTICALS INC.
  • PIRAMAL HEALTHCARE LTD.
  • POLAR ELECTRO OY
  • PRESTIGE BRANDS HOLDINGS INC.
  • PREVENTICE INC.
  • PRIZM MEDICAL INC.
  • PROPELLER HEALTH
  • PROTEOSTASIS THERAPEUTICS
  • PROTEUS DIGITAL HEALTH INC.
  • QARDIO
  • RECKITT BENCKISER(NORTH AMERICA) INC.
  • RECKITT BENCKISER PLC.
  • RECORDATI PHARMA GMBH
  • REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
  • REVOLYMER(UK) LTD
  • REXAHN PHARMACEUTICALS
  • ROCHE
  • SAGE PRODUCTS LLC
  • SAGE THERAPEUTICS
  • SANOFI
  • SAREPTA THERAPEUTICS
  • SATO PHARMACEUTICAL CO. LTD.
  • SENSE4CARE
  • SENSEONICS HOLDINGS
  • SENTICARE INC.
  • SHAKLEE CORP.
  • SHANGHAI PHARMACEUTICALS HOLDING
  • SHIONOGI AND CO. LTD.
  • SILVERGENS
  • SPROUTLING INC. (ACQUIRED BY MATTEL)
  • ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
  • STADA ARZNEIMITTEL AG
  • SUMITOMO DAINIPPON PHARMA CO. LTD.
  • SUN PHARMACEUTICAL INDUSTRIES
  • SWISSE WELLNESS PTY LTD.
  • TAISHO PHARMACEUTICAL HOLDINGS
  • TAISHO PHARM
  • TAKEDA PHARMACEUTICAL CO. LTD.
  • TCR2 THERAPEUTICS
  • TEVA PHARMACEUTICAL INDUSTRIES
  • TISSO NATURPRODUKTE GMBH
  • TOWERVIEW HEALTH INC.
  • TRANSLATE BIO
  • TYME TECHNOLOGIES
  • UCB
  • UNILIFE CORP.
  • VAICA
  • VERTEX PHARMACEUTICAL
  • VITAL CONNECT
  • WELLSPRING PHARMACEUTICAL CORP.
  • WEST PHARMACEUTICAL SERVICES INC.
  • WINMEDICAL SRL
  • YBRAIN
  • YPSOMED HOLDING AG
  • ZEAVISION LLC
  • ZOGENIX INC.
  • ZYDUS CADILA

제14장 부록 A : 약어 리스트

제15장 부록 B : 전문기관 리스트

LSH 20.07.06

List of Tables

  • Summary Table : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, Through 2024
  • Table 1 : Global Incidence Share of Hypertension, by Patient Group Type, 2019
  • Table 2 : Global Prevalence of Angina Pectoris and Stroke (Survivors), Through 2030
  • Table 3 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
  • Table 4 : Structural Heart Disease Management Through Medication
  • Table 5 : BMI Calculation
  • Table 6 : BMI Categories Based on Increasing Health Risks
  • Table 7 : Trends in Obesity Composition of the World's Population, Through 2025
  • Table 8 : Obesity and Severe Obesity vs. General Population in U.S., Through 2025
  • Table 9 : Global Share of Diabetes, by Type
  • Table 10 : Global Prevalence of Diabetes, by Type, Through 2040
  • Table 11 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, Through 2025
  • Table 12 : Global Deaths, by Various Musculoskeletal Disorders, Through 2030
  • Table 13 : Global Deaths from Digestive Diseases, by Region, Through 2025
  • Table 14 : Global Deaths Share, by Various Chronic Disease Types, 2018
  • Table 15 : Global DALYs Share, by Various Chronic Disease Types, 2018
  • Table 16 : Estimated World Population and Annual Growth, by Age Group, Through 2030
  • Table 17 : World Population, by Country/Region, Through 2030
  • Table 18 : U.S. Population Estimates and Projections, by Age Group, Through 2030
  • Table 19 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
  • Table 20 : European Population Estimates and Projections, by Age Group, Through 2030
  • Table 21 : Japanese Population Estimates and Projections, by Age Group, Through 2030
  • Table 22 : Key Marketed OTC Drugs
  • Table 23 : Cardiac Monitoring Devices and Technologies, by Company
  • Table 24 : Key Continuous Glucose Monitoring Devices and Technologies, by Company
  • Table 25 : Sleep-Monitoring Devices and Technologies, by Company
  • Table 26 : Key Vital Sign and Activity Monitoring Devices and Technologies, by Company
  • Table 27 : Pain Management Devices and Technologies, by Company
  • Table 28 : Drug Delivery Devices and Technologies, by Company
  • Table 29 : Insulin Delivery Devices and Technologies, by Company
  • Table 30 : Global Medication Adherence Percentages, by Chronic Diseases
  • Table 31 : Smart Pill Dispensers, Pillboxes and Organizers, by Company
  • Table 32 : Medication Tracking Devices and Apps, by Company
  • Table 33 : Pill Organizer and Reminder Systems, by Company
  • Table 34 : Smart Pill Cap and Bottle Systems, by Company
  • Table 35 : Other Medication Adherence Solutions, by Company
  • Table 36 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, Through 2024
  • Table 37 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, Through 2024
  • Table 38 : Global Market for OTC Treatment Adherence Devices, Through 2024
  • Table 39 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Disease Type, Through 2024
  • Table 40 : SWOT Analysis of the OTC Drugs, Medical Devices and Diagnostics Market
  • Table 41 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Company, 2019
  • Table 42 : Key Strategic Deals in the OTC Medical Devices and Diagnostics Market, by Company, 2012-2019
  • Table 43 : Key Strategic Deals in OTC Drugs and Nutritional Product/Supplement Market, by Company, 2016-2019
  • Table 44 : Key Strategic Deals for Business Units, Minority Stakes and Future Options to Acquire in the OTC Market, by Company, 2016-2019
  • Table 45 : Differences in Regulatory Approval in the U.S. and Europe
  • Table 46 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
  • Table 47 : List of Acronyms used in OTC Drugs, Medical Devices and Diagnostics

List of Figures

  • Summary Figure : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, 2018-2024
  • Figure 1 : Global Incidence Share of Hypertension, by Patient Group Type, 2019
  • Figure 2 : Global Prevalence of Angina Pectoris and Stroke (Survivors), 2004-2030
  • Figure 3 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
  • Figure 4 : Trends in Obesity Composition of the World's Population, 2012-2025
  • Figure 5 : Obesity and Severe Obesity vs. General Population in U.S., 2018 and 2025
  • Figure 6 : Global Share of Diabetes, by Type
  • Figure 7 : Global Prevalence of Diabetes, by Type, 2018 and 2040
  • Figure 8 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, 2012-2025
  • Figure 9 : Global Deaths Share, by Various Musculoskeletal Disorders, 2015
  • Figure 10 : Global Deaths from Digestive Diseases, by Region, 2015-2025
  • Figure 11 : Global Deaths Share, by Various Chronic Disease Types, 2018
  • Figure 12 : Global DALYs Share, by Various Chronic Disease Types, 2018
  • Figure 13 : Estimated World Population and Annual Growth, by Age Group, 2000-2030
  • Figure 14 : World Population, by Country/Region, 2000-2030
  • Figure 15 : U.S. Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 16 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
  • Figure 17 : European Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 18 : Japanese Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 19 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, 2018-2024
  • Figure 20 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, 2018-2024
  • Figure 21 : Global Market Share for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, 2019
  • Figure 22 : Global Market Share for OTC Drugs and Nutritional Supplements, by Therapeutic Classification, 2019
  • Figure 23 : Global Market Share for Device Technologies, by Device Type, 2019
  • Figure 24 : Global Market for OTC Treatment Adherence Devices, 2018-2024
  • Figure 25 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Disease Type, 2018-2024
  • Figure 26 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018

Highlights:

The global market for OTC drugs, medical devices and diagnostics should grow from $259 billion in 2019 to $361 billion by 2024 at compound annual growth rate (CAGR) of 6.9% for the period of 2019-2024.

U.S. market for OTC drugs, medical devices and diagnostics should grow from $91 billion in 2019 to $128 billion by 2024 at a CAGR of 7.1% for the period of 2019-2024.

Asia-Pacific market for OTC drugs, medical devices and diagnostics should grow from $57 billion in 2019 to $83 billion by 2024 at a CAGR of 7.8% for the period of 2019-2024.

Report Scope:

This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for OTC drugs, medical devices and diagnostic kits used for self-care and the management of various common diseases.

The report considers only "Western" or modern drugs and excludes any other type of drugs such as alternative therapies. This report covers medical devices and diagnostic kits exempted by the U.S. FDA for OTC use.

This study aims to provide an understanding of the dynamics and forecasts of the OTC drugs, medical devices and diagnostic kits market worldwide and provides key market propositions over a five-year forecast period.

The report covers developed and emerging markets in order to help readers understand -

  • Detailed description, including demographics and cost burden, of various diseases including cardiovascular diseases, orthopedic diseases, respiratory disorders, diabetes, obesity, gastrointestinal disorders, sleep disorders, skin disorders, and ENT disorders.
  • Detailed description and analysis of current OTC drugs, medical devices and diagnostic kits.
  • Market characterization, unmet need, and market size and segmentation (by region, by segment, by diseases).
  • The current state of the market and the key markets for its future development.
  • Major regional trends.
  • Market drivers and restraints.
  • Detailed market projections through 2024.
  • Global competitive thrust in terms of competition and market shares.
  • Key marketed and pipeline (research and development) products along with information about their regulatory status.
  • Strategic landscape (mergers and acquisitions).
  • Regulatory structure: new regulations that will influence the development of the OTC drugs, devices and diagnostics market.
  • Pricing and reimbursement.
  • Observations and conclusions on the future of OTC drugs, medical devices and diagnostics.
  • Profiles of market participants and associations.

Report Includes:

  • 26 data tables and 22 additional tables
  • An overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics
  • Analyses of global market trends with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Coverage of various target diseases, including common health disorders and severe chronic diseases where OTC drugs and devices play a key role in the management of diseases
  • Assessment of the recent breakthroughs, current research activities, technological hurdles and latest trends related to the field of medical technologies
  • Complete understanding about the usage and adoption rate of OTC drugs, devices and diagnostic kits in various regions
  • Underlying details of key business opportunities to pivotal stakeholders to expand of business and capture the revenue in the specific verticals to analyze before investing or expanding the horizon within this market
  • Competitive landscape encompassing a large chunk of small, medium and large players on both pharmaceutical drugs and medical devices and diagnostics side
  • Profile description of leading market players, including 3M, Akron, Bayer AG, Celgene, and Eli Lilly and Co.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Target Diseases and Disorders

  • Overview of Common Diseases and Disorders for OTC
  • Cardiovascular Disease
  • Lifestyle Disorders
  • Respiratory Disorders
  • Musculoskeletal Disorders
  • Mental/Mood Disorders
  • Gastrointestinal Disorders
  • Urology Disorders
  • Chronic Wounds
  • Chronic Pain
  • Panic Disorder/Anxiety Disorder
  • ENT Disorders
  • Dental Disorders
  • Eating Disorders
  • Tobacco Smoking and Associated Diseases
  • Chronic Diseases: Expanding Horizon for OTC Market
  • Aging, Gender and Onset of Diseases
  • Global Demographics
  • U.S. Demographics
  • U.S.: Gender, Age and Life Expectancy
  • European Demographics
  • Japanese Demographics
  • Current Challenges and Future Directions

Chapter 4 OTC Drugs and Nutritional Supplements

  • OTC Therapeutics Overview
  • Evolution of OTC drugs
  • Clinical Need of Drugs
  • Drug-Based Disease Management
  • Generic Drugs and Disease Management
  • Generic Drugs vs. Branded Drugs
  • Continued Resistance to Generics
  • OTC Drugs and Types
  • OTC Analgesics/Antipyretics
  • OTC Antihistamine and Cough and Cold Drugs
  • OTC Gastrointestinal Products
  • OTC Dermatological Drugs
  • OTC Oral Medical Care Products
  • OTC Eye Care Products
  • OTC Smoking Cessation Products
  • Key Marketed OTC Drugs
  • OTC Dietary Supplements and Types
  • Eating Disorders
  • Treatments for Vitamin and Mineral Deficiency
  • Vitamin and Mineral Supplements (VMS)
  • Distribution Channel for OTC
  • Multinational OTC Drug Manufacturers
  • Drug Stores and Other Chain Store Brands
  • FMCGs
  • Practice of OTC Drug Purchase
  • Regulatory Influence on OTC Drug Market
  • Market Situation for OTC Drugs and Dietary Supplements
  • Well-Developed Markets
  • Developing Markets
  • Underdeveloped Markets
  • Therapeutics and Cost Burden
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 5 OTC Medical Devices and Diagnostics

  • Medical Devices, Diagnostics and Disease Management
  • Clinical and Market Need of OTC Devices and Diagnostics
  • Types of OTC Devices and Diagnostics
  • Self-Care Devices and Wearables
  • Diagnostic Devices and Kits
  • Key Products
  • Diagnostic and Monitoring Devices
  • Therapeutic Devices and Technologies
  • Remote Patient Monitoring and Home Healthcare
  • Advantages of Disease Management via Digital Care
  • Unmet Need
  • Current Challenges
  • Future Outlook

Chapter 6 OTC Devices for Treatment Adherence

  • Treatment Nonadherence
  • Market Need for OTC Medication Adherence Devices
  • Hardware-Centric OTC Medication Adherence Devices
  • Smart Pill Bottle
  • Automated Pill Dispenser
  • Electronic Tray
  • Smart Caps
  • Other Adherence Devices and Solutions
  • Key Products
  • Smart Pill Dispensers, Pillboxes, Organizers, Smart Pill Cap and Bottle Systems
  • Other OTC Adherence Devices
  • Current Challenges
  • Future Developments

Chapter 7 Market Size and Growth Analysis

  • Market Size and Growth Analysis
  • Market Size and Growth Analysis, by Region
  • Market Size and Growth Analysis, by Product Segment
  • Market Size and Growth Analysis, by Disease Type
  • Market Growth Drivers and Restraints
  • Market Growth Drivers
  • Market Restraints
  • Regulatory Impact on the OTC Market
  • Brexit Effect on the OTC Market in Europe
  • SWOT Analysis of OTC Market

Chapter 8 Competitive Landscape in the OTC Drugs, Medical Devices and Diagnostics Market

  • Competitive Landscape: Disease Treatment and Management with OTC Drugs, Medical Devices and Diagnostic Technologies

Chapter 9 Strategies in the OTC Drugs, Medical Devices and Diagnostics Market

  • Consolidation in the OTC Drugs and Devices Market
  • Mergers and Acquisitions in the OTC Drugs, Medical Devices and Diagnostics Market
  • OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
  • OTC Medical Devices and Diagnostics
  • Recent Mergers and Acquisitions
  • OTC Medical Devices and Diagnostics
  • OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
  • Minority Stakes and Future Options to Acquire
  • Future Strategic Landscape

Chapter 10 Regulatory Structure: Pharmaceuticals, Medical Devices and Diagnostics

  • Regulatory Background
  • Regulatory Systems for Medical Devices, by Region
  • U.S.
  • European Union
  • Japan
  • Regulatory Systems for Pharmaceuticals, by Region
  • U.S.
  • Europe
  • Japan
  • Rules and Regulations for OTC Drugs and Dietary Supplements
  • Regulations for OTC drugs
  • Regulations for Dietary Supplements

Chapter 11 Pricing and Reimbursement: Pharmaceuticals, Medical Devices and Diagnostics

  • Pricing and Reimbursement Background
  • Pricing and Reimbursement for Medical Devices, by Region
  • U.S.
  • Europe
  • Japan
  • Other Asia-Pacific
  • Pricing and Reimbursement for Pharmaceuticals, by Region
  • U.S.
  • Europe
  • Japan

Chapter 12 Conclusions-Outlook for OTC Drugs, Medical Devices and Diagnostics

  • Major Developments Influencing the Market
  • Technological Developments
  • Demographic and Economic Trends
  • Changing Structure of the Healthcare Industry
  • Lifestyle Medicine
  • Patient-Centric Programs
  • Prevalence of Self-Care
  • Burden on Public Health System
  • Retain Market Leadership
  • Long-Term Outlook

Chapter 13 Company Profiles

  • 3M
  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • ACADIA PHARMACEUTICAL
  • ACORDA THERAPEUTICS
  • ACTAVIS PLC
  • ACTUALMEDS
  • ADHERIUM
  • AETHLON MEDICAL INC.
  • AGENUS
  • AKRON
  • ALACER CORP.
  • ALCON INC.
  • ALERE INC.
  • ALFRESA PHARMA CORP.
  • ALIPHCOM INC.
  • ALIVECOR
  • ALKALON A/S
  • ALKERMES
  • ALLERGAN
  • ALLIANCE HEALTHCARE
  • AMGEN INC.
  • AMIKO
  • AMNEAL PHARMACEUTICALS
  • ANAVEX LIFE SCIENCES
  • ANI PHARMACEUTICALS
  • ANIMAS (A SUBSIDIARY OF JOHNSON & JOHNSON)
  • APOTEX
  • ARCHOS
  • ARENA PHARMACEUTICALS
  • ARRAY BIOPHARMA
  • ASAHI KASAI CORP.
  • ASLAN PHARMACEUTICALS
  • ASPEN PHARMACARE
  • ASSERTIO THERAPEUTICS, INC.
  • ASTELLAS PHARMA INC.
  • ASTRAZANECA PLC
  • ATHERSYS
  • AUDENTES THERAPEUTICS
  • AXIOBIONICS
  • AXSOME THERAPEUTICS
  • BAUSCH & LOMB
  • BAUSCH HEALTH
  • BAXTER INTERNATIONAL INC.
  • BAYER AG
  • BEIGENE
  • BESPAK EUROPE
  • BIOMERIEUX
  • BIOSENSICS
  • BIOSERENITY
  • BIOTRICITY
  • BIOTRONIK
  • BIOVOTION
  • BIOXCEL THERAPEUTICS
  • BODYTEL
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRAINMARC
  • BRISTOL-MYERS SQUIBB
  • BTS BIOENGINEERING
  • CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
  • CARMA LABORATORIES, INC.
  • CELGENE
  • CHATTEM INC.
  • CHUGAI PHARMACEUTICALS CO. LTD.
  • CILAG AG
  • CIPLA
  • CLEVELAND MEDICAL DEVICES
  • COLGATE-PALMOLIVE CO.
  • CONNECTEDHEALTH PTE. LTD.
  • CONSORT MEDICAL
  • CORBUS PHARMACEUTICALS
  • CSPC PHARMACEUTICAL GROUP
  • DAIICHI SANKYO
  • DERMA SCIENCES
  • DEXCOM INC.
  • DR. REDDY'S LABORATORIES LTD.
  • EARLYSENSE
  • EISAI
  • ELI LILLY AND CO.
  • EMPATICA
  • ENDO INTERNATIONAL
  • ENDOCEUTICS INC.
  • ENDOTRONIX
  • ENTRA HEALTH SYSTEMS
  • ERYTECH PHARMA
  • ESTEVE
  • EVERIST HEALTH
  • EYESCIENCE LABS
  • FERTIN PHARMA A/S
  • GABA SCHWEIZ
  • GALDERMA S.A.
  • GEMINI PHARMACEUTICALS INC.
  • GENOMMA LAB INTERNATIONAL
  • GENOMMA LAB USA
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • GLOOKO INC.
  • GLUCOVISTA INC.
  • HEALTH CARE ORIGINALS
  • HIKMA PHARMACEUTICALS
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • HOCOMA
  • IHEALTH LAB INC.
  • IMMUNOMEDICS
  • IMPACT SPORTS TECHNOLOGIES
  • IMPAK HEALTH
  • INFOBIONIC INC.
  • INSULET CORP.
  • INTELESENS
  • INTRA-CELLULAR THERAPIES
  • IOVANCE BIOTHERAPEUTICS
  • IPSEN S.A.
  • JAN MEDICAL INC.
  • JIANGSU HENGRUI MEDICINE
  • JOHNSON & JOHNSON
  • KOWA CO. LTD.
  • KYOWA HAKKO KIRIN
  • LAKE CONSUMER PRODUCTS INC.
  • LES LABORATOIRES SERVIER
  • LIVANOVA PLC
  • LUNDBECK
  • LUPIN
  • MALLINCKRODT PLC
  • MANX HEALTHCARE LTD.
  • MCM KLOSTERFRAU VERTRIEBS GMBH (KLOSTERFRAU HEALTHCARE GROUP)
  • MEDA AB
  • MEDMINDER
  • MEDTRONIC
  • MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
  • MELALEUCA INC.
  • MENARINI
  • MERCK
  • MERZ PHARMA
  • MIO GLOBAL
  • MITSUBISHI TANABE PHARMA
  • MOCHIDA PHARMACEUTICAL CO. LTD.
  • MYCARDIO LLC
  • MYLAN INC.
  • NEMAURA MEDICAL INC.
  • NEOFECT CO. LTD.
  • NEUROCRINE BIOSCIENCES
  • NEUROMETRIX INC.
  • NEUROVIGIL INC.
  • NEUTROGENA CORP.
  • NORTHEAST PHARMACEUTICAL GROUP CO. LTD.
  • NOVARTIS
  • NOVASOM INC.
  • NOVO NORDISK
  • NOW FOODS
  • NUCANA
  • OMADA HEALTH INC.
  • OMNICELL INC.
  • OMRON CORP.
  • ONO PHARMACEUTICAL CO. LTD.
  • ORION PHARMA LTD.
  • ORPYX MEDICAL TECHNOLOGIES
  • OTSUKA PHARMACEUTICALS
  • PACIRA PHARMACEUTICALS INC.
  • PERRIGO PLC
  • PFIZER
  • PGT HEALTHCARE (DIVISION OF PROCTER & GAMBLE)
  • PHARMAVITE LLC
  • PHILOSYS
  • PIERRE FABRE PHARMACEUTICALS INC.
  • PIRAMAL HEALTHCARE LTD.
  • POLAR ELECTRO OY
  • PRESTIGE BRANDS HOLDINGS INC.
  • PREVENTICE INC.
  • PRIZM MEDICAL INC.
  • PROPELLER HEALTH
  • PROTEOSTASIS THERAPEUTICS
  • PROTEUS DIGITAL HEALTH INC.
  • QARDIO
  • RECKITT BENCKISER (NORTH AMERICA) INC.
  • RECKITT BENCKISER PLC.
  • RECORDATI PHARMA GMBH
  • REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
  • REVOLYMER (U.K.) LTD
  • REXAHN PHARMACEUTICALS
  • ROCHE
  • SAGE PRODUCTS LLC
  • SAGE THERAPEUTICS
  • SANOFI
  • SAREPTA THERAPEUTICS
  • SATO PHARMACEUTICAL CO. LTD.
  • SENSE4CARE
  • SENSEONICS HOLDINGS
  • SENTICARE INC.
  • SHAKLEE CORP.
  • SHANGHAI PHARMACEUTICALS HOLDING
  • SHIONOGI AND CO. LTD.
  • SILVERGENS
  • SPROUTLING INC. (ACQUIRED BY MATTEL)
  • ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
  • STADA ARZNEIMITTEL AG
  • SUMITOMO DAINIPPON PHARMA CO. LTD.
  • SUN PHARMACEUTICAL INDUSTRIES
  • SWISSE WELLNESS PTY LTD.
  • TAISHO PHARMACEUTICAL HOLDINGS
  • TAISHO PHARMACEUTICAL
  • TAKEDA PHARMACEUTICAL CO. LTD.
  • TCR2 THERAPEUTICS
  • TEVA PHARMACEUTICAL INDUSTRIES
  • TISSO NATURPRODUKTE GMBH
  • TOWERVIEW HEALTH INC.
  • TRANSLATE BIO
  • TYME TECHNOLOGIES
  • UCB
  • UNILIFE CORP.
  • VAICA
  • VERTEX PHARMACEUTICAL
  • VITAL CONNECT
  • WELLSPRING PHARMACEUTICAL CORP.
  • WEST PHARMACEUTICAL SERVICES INC.
  • WINMEDICAL SRL
  • YBRAIN
  • YPSOMED HOLDING AG
  • ZEAVISION LLC
  • ZOGENIX INC.
  • ZYDUS CADILA

Chapter 14 Appendix A: List of Acronyms

Chapter 15 Appendix B: Professional Organizations

  • American Heart Association
  • Center for Drug Evaluation and Research (CDER)
  • Center for Devices and Radiological Health (CDRH)
  • Centers for Medicare and Medicaid Services (CMS)
  • European Databank for Medical Devices (EUDAMED)
  • Food and Drug Administration (FDA or U.S. FDA)
  • Hormone Foundation
  • International Diabetes Federation (IDF)
  • International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
  • Network for Excellence in Health Innovation (NEHI)
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Aging (NIA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • World Cancer Research Fund International
  • World Health Organization (WHO)
Back to Top
전화 문의
F A Q